Teicoplanin Bradex 200 mg and 400 mg powder and liquid for injection/infusion, solution 6 ml vial
Powder and liquid for injection/infusion, solution
Powder: White to off-white freeze-dried powder.
Liquid: Clear, colorless solution.
Teicoplanin Bradex is indicated for adults and children from birth for parenteral treatment of the following
infections (see sections 4.2, 4.4 and 5.1):
complicated skin and soft tissue infections
bone tissue and joint infections
community acquired pneumonia
complicated urinary tract infections
peritonitis associated with continuous ambulatory peritoneal dialysis (CAPD)
bacteremia arising in connection with any of the indications listed above.
Teicoplanin Bradex is also indicated as an alternative oral treatment for Clostridium difficile infection-associated diarrhea and colitis.
Powder and solution packaged for sale do not require special storage conditions.
•200 mg, carton x 1 vial x 200 mg + 1 ampoule x 3 ml diluent.
•400 mg carton x 1 vial x 400 mg + 1 ampoule x 3 ml diluent
•Vnr: 120994 Teicoplanin Bradex 200 mg
•Vnr: 170679 Teicoplanin Bradex 400 mg
For more information and training materials:
The page was last updated on 21/09/2020